CIBC Private Wealth Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.69M | Sell |
20,329
-600
| -3% | -$49.8K | ﹤0.01% | 582 |
|
2025
Q1 | $1.46M | Buy |
20,929
+1,473
| +8% | +$103K | ﹤0.01% | 592 |
|
2024
Q4 | $1.8M | Buy |
19,456
+5,117
| +36% | +$472K | ﹤0.01% | 592 |
|
2024
Q3 | $1.42M | Buy |
14,339
+7,929
| +124% | +$783K | ﹤0.01% | 631 |
|
2024
Q2 | $598K | Buy |
6,410
+2,815
| +78% | +$262K | ﹤0.01% | 775 |
|
2024
Q1 | $337K | Buy |
+3,595
| New | +$337K | ﹤0.01% | 935 |
|
2022
Q4 | – | Sell |
-10,053
| Closed | -$798K | – | 952 |
|
2022
Q3 | $798K | Sell |
10,053
-2,899
| -22% | -$230K | ﹤0.01% | 634 |
|
2022
Q2 | $962K | Buy |
12,952
+9,733
| +302% | +$723K | ﹤0.01% | 600 |
|
2022
Q1 | $290K | Buy |
3,219
+160
| +5% | +$14.4K | ﹤0.01% | 856 |
|
2021
Q4 | $342K | Hold |
3,059
| – | – | ﹤0.01% | 845 |
|
2021
Q3 | $385K | Sell |
3,059
-5,653
| -65% | -$711K | ﹤0.01% | 775 |
|
2021
Q2 | $1.18M | Buy |
8,712
+2,280
| +35% | +$309K | ﹤0.01% | 630 |
|
2021
Q1 | $872K | Buy |
6,432
+116
| +2% | +$15.7K | ﹤0.01% | 695 |
|
2020
Q4 | $889K | Sell |
6,316
-418
| -6% | -$58.8K | ﹤0.01% | 656 |
|
2020
Q3 | $750K | Buy |
+6,734
| New | +$750K | ﹤0.01% | 612 |
|
2020
Q2 | – | Sell |
-2,644
| Closed | -$205K | – | 828 |
|
2020
Q1 | $205K | Sell |
2,644
-65
| -2% | -$5.04K | ﹤0.01% | 798 |
|
2019
Q4 | $258K | Sell |
2,709
-571
| -17% | -$54.4K | ﹤0.01% | 828 |
|
2019
Q3 | $250K | Sell |
3,280
-63
| -2% | -$4.8K | ﹤0.01% | 818 |
|
2019
Q2 | $293K | Sell |
3,343
-1,079
| -24% | -$94.6K | ﹤0.01% | 822 |
|
2019
Q1 | $400K | Buy |
4,422
+804
| +22% | +$72.7K | ﹤0.01% | 766 |
|
2018
Q4 | $260K | Buy |
3,618
+300
| +9% | +$21.6K | ﹤0.01% | 793 |
|
2018
Q3 | $318K | Buy |
3,318
+448
| +16% | +$42.9K | ﹤0.01% | 853 |
|
2018
Q2 | $273K | Buy |
2,870
+72
| +3% | +$6.85K | ﹤0.01% | 869 |
|
2018
Q1 | $245K | Sell |
2,798
-50
| -2% | -$4.38K | ﹤0.01% | 903 |
|
2017
Q4 | $242K | Sell |
2,848
-43
| -1% | -$3.65K | ﹤0.01% | 906 |
|
2017
Q3 | $250K | Buy |
+2,891
| New | +$250K | ﹤0.01% | 869 |
|